Intco Medical Technology Co., Ltd.

SZSE:300677.SZ

22.44 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 2,293.0872,187.7151,876.7281,747.0471,722.0311,572.9191,401.5551,471.7881,452.6062,287.8652,593.4692,972.243,939.7226,734.6624,891.7934,495.1263,676.461773.335557.651541.013490494.271517.019501.481450.201423.84442.297447.73462.552397.898330.38310.389275.442266.896
Cost of Revenue 1,818.9061,748.2111,567.731,460.2281,490.9991,452.0661,277.7981,384.8051,212.7631,870.3511,563.1171,548.341,151.8791,988.2891,469.8911,081.9381,223.648509.833407.368407.716365.581379.447382.977374.647339.571323.308328.7320.191349.267316.139244.848245.025205.531197.9
Gross Profit 474.181439.504308.998286.819231.032120.853123.75786.983239.843417.5141,030.3521,423.92,787.8434,746.3733,421.9023,413.1882,452.813263.501150.283133.297124.419114.824134.042126.835110.63100.532113.597127.539113.28581.75985.53265.36469.9168.996
Gross Profit Ratio 0.2070.2010.1650.1640.1340.0770.0880.0590.1650.1820.3970.4790.7080.7050.70.7590.6670.3410.2690.2460.2540.2320.2590.2530.2460.2370.2570.2850.2450.2050.2590.2110.2540.259
Reseach & Development Expenses 98.16284.57982.09767.56469.83263.8853.90358.28870.56369.568100.66480.54181.048102.97299.143106.68169.73217.74515.86419.21919.59912.91316.68818.3316.75910.78115.0515.40426.461038.148014.390
General & Administrative Expenses -42.918118.175-225.592292.136-30.408117.336-198.653246.03-31.34114.066-91.418275.355-2.459104.011-22.93974.82211.70330.611-28.67123.290.06317.054-29.71823.722-9.55427.485-58.85832.60526.63924.567-39.63521.84938.2660
Selling & Marketing Expenses 68.74467.89973.48369.28558.1850.85542.09973.1934.52598.01119.24185.00674.049105.416-32.257126.453166.26963.1738.95429.4433.51430.45933.26533.51927.02625.82829.46825.67426.74424.77533.32522.21936.6990
SG&A 175.94200.991-152.109361.42127.771168.19-156.555319.224-26.814212.07627.823360.36171.589209.427-55.196201.274177.97293.78110.28352.7333.57747.5133.54757.24117.47253.313-29.3958.27954.95149.342-6.3144.06875.7170
Other Expenses -9.241-0.367207.157-96.78773.9712.839294.058-133.418140.549-2.8793.459-24.94215.922-1.811-6.65-2.541-11.1050.1752.062-0.059-0.568-0.2094.39-0.631-1.1870.122-6.0530.594-63.26-57.5580.310.087-38.547-41.457
Operating Expenses 283.343285.937282.765272.552258.434234.909191.407244.094184.298278.765404.36309.825281.53320.697169.904326.365296.974115.05480.80174.49179.67163.42875.29676.91567.8156.88966.06760.032-63.26-57.55864.27644.452-38.547-41.457
Operating Income 190.839153.567-30.1424.778594.451-150.098-149.931241.059431.275108.518586.4131,151.9982,526.2934,424.0213,106.4022,974.1172,137.084151.32657.33762.07644.34538.69649.37169.14758.66626.32734.31659.90450.02524.20124.90616.40931.36327.539
Operating Income Ratio 0.0830.07-0.0160.0140.345-0.095-0.1070.1640.2970.0470.2260.3880.6410.6570.6350.6620.5810.1960.1030.1150.090.0780.0950.1380.130.0620.0780.1340.1080.0610.0750.0530.1140.103
Total Other Income Expenses Net 179.984138.79231.59-8.028-14.788-4.94514.68573.434-10.985-3.642-29.20128.54820.335-3.466-154.416-115.247-29.863.053-10.493.21-0.971-12.909-4.57718.59714.659-17.194-16.432-7.92640.955-57.5283.288-4.48137.691-41.544
Income Before Tax 370.823292.3591.44916.75579.663-155.043-135.246314.494420.29104.876557.2121,142.6232,526.6484,422.213,097.5822,971.5762,125.979151.50158.99362.01743.77738.48754.16968.51757.47926.44931.09859.58147.94724.2324.54416.43129.70727.452
Income Before Tax Ratio 0.1620.1340.0010.010.337-0.099-0.0960.2140.2890.0460.2150.3840.6410.6570.6330.6610.5780.1960.1060.1150.0890.0780.1050.1370.1280.0620.070.1330.1040.0610.0740.0530.1080.103
Income Tax Expense 19.44551.793-49.359-16.021128.407-8.274-141.71185.62795.74925.40560.39956.621380.229687.973465.217520.539333.98622.3856.4947.0966.7734.6433.68.85610.8413.977-2.1868.78450.328-53.6792.3892.18742.035-36.848
Net Income 348.83238.19852.14637.695446.213-146.7696.465236.208318.84683.493487.5671,063.6932,143.0933,735.7232,634.4692,451.2781,792.112129.1952.54954.9237.00433.84450.56859.6646.63822.47233.28450.79740.65220.58822.15514.24427.0222.843
Net Income Ratio 0.1520.1090.0280.0220.259-0.0930.0050.160.2190.0360.1880.3580.5440.5550.5390.5450.4870.1670.0940.1020.0760.0680.0980.1190.1040.0530.0750.1130.0880.0520.0670.0460.0980.086
EPS 0.540.370.110.0590.69-0.230.010.420.570.130.752.064.156.038.126.294.070.240.120.10.0830.0630.110.110.110.0420.0830.110.10.0520.0680.0360.0820.058
EPS Diluted 0.540.360.110.0590.69-0.230.010.420.570.130.752.064.155.738.125.944.070.230.120.0950.0830.0630.110.110.110.0420.0830.110.10.0520.0680.0360.0820.058
EBITDA 382.803301.884184.269-65.4612.666-131.475-20.056251.357421.91121.178603.6231,145.6362,506.2274,474.443,104.3842,966.9562,144.968167.2863.76571.77651.68943.12462.12173.12649.22142.57224.0168.717-1.77481.75924.76323.624-7.98468.996
EBITDA Ratio 0.1670.1380.098-0.0370.356-0.084-0.0140.1710.290.0530.2330.3850.6360.6640.6350.660.5830.2160.1140.1330.1050.0870.120.1460.1090.10.0540.153-0.0040.2050.0750.076-0.0290.259